Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
731
-
Total shares
-
75.5M
-
Shares change
-
+1.37M
-
Total reported value, excl. options
-
$18.3B
-
Value change
-
+$318M
-
Put/Call ratio
-
1.14
-
Number of buys
-
319
-
Number of sells
-
-366
-
Price
-
$242.24
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q1 2020
739 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q1 2020.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 731 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.5M shares
of 80.8M outstanding shares and own 93.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.68M shares), BlackRock Inc. (7.87M shares), Fundsmith LLP (4.25M shares), STATE STREET CORP (3.8M shares), BAMCO INC /NY/ (3.54M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.36M shares), GEODE CAPITAL MANAGEMENT, LLC (1.58M shares), BLAIR WILLIAM & CO/IL (1.56M shares), ALLIANCEBERNSTEIN L.P. (1.26M shares), and PRINCIPAL FINANCIAL GROUP INC (1.24M shares).
This table shows the top 731 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.